Increased prevalence of inhibitors in Hispanic patients with severe haemophilia A enrolled in the Universal Data Collection database
- 18 January 2012
- journal article
- Published by Wiley in Haemophilia
- Vol. 18 (3), e260-e265
- https://doi.org/10.1111/j.1365-2516.2011.02739.x
Abstract
Neutralizing inhibitors develop in 20-30% of patients with severe factor VIII (FVIII) deficiency. It is well established that Blacks have a higher prevalence of inhibitors than Whites. This is the first study to definitively demonstrate increased inhibitor prevalence in the Hispanic population. We compared inhibitor prevalence among various racial and ethnic groups in a cross-sectional analysis of 5651 males with severe haemophilia A that participated in the Universal Data Collection project sponsored by the Centers for Disease Control and Prevention. We used logistic regression analysis to control for potential confounding variables. We assigned as Hispanic those participants who were white and labelled themselves Hispanic. The prevalence of high-titre inhibitors in the Hispanic participants was 24.5% compared to 16.4% for White non-Hispanic patients (OR 1.4, 95% CI 1.1, 1.7). Possibilities as to the underlying cause of increased inhibitor prevalence in minority ethnic populations include polymorphisms in the FVIII molecule, HLA subtypes and differing inflammatory responses. A better understanding may lead to tailored treatment programmes, or other therapies, to decrease or prevent inhibitor development.Keywords
This publication has 29 references indexed in Scilit:
- Impact of polymorphisms of the major histocompatibility complex class II, interleukin‐10, tumor necrosis factor‐α and cytotoxic T‐lymphocyte antigen‐4 genes on inhibitor development in severe hemophilia AJournal of Thrombosis and Haemostasis, 2009
- Risk factors for inhibitor formation in haemophilia: a prevalent case–control studyHaemophilia, 2009
- Disparities in allele frequencies and population differentiation for 101 disease-associated single nucleotide polymorphisms between Puerto Ricans and non-Hispanic whitesBMC Genomic Data, 2009
- Inhibitors of Factor VIII in Black Patients with HemophiliaNew England Journal of Medicine, 2009
- Factor VIII genotype and inhibitor development in patients with haemophilia A: highest risk in patients with splice site mutationsHaemophilia, 2008
- A Genomewide Admixture Map for Latino PopulationsAmerican Journal of Human Genetics, 2007
- Frequency of intron 1 and 22 inversions offactor VIII gene in Mexican patients with severe hemophilia AAmerican Journal of Hematology, 2007
- Genetic Structure Analysis of Three Hispanic Populations from Costa Rica, Mexico, and the Southwestern United States Using Y-Chromosome STR Markers and mtDNA SequencesHuman Biology, 2006
- Risk of inhibitors in haemophilia and the type of factor replacementCurrent Opinion in Hematology, 2006
- Why do inhibitors develop? Principles of and factors influencing the risk for inhibitor development in haemophiliaHaemophilia, 2006